{"id":"placebo-of-n-acetylcysteine","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL600","moleculeType":"Small molecule","molecularWeight":"163.20"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a placebo of N-acetylcysteine, this formulation contains no active drug and serves as a control comparator in clinical trials. N-acetylcysteine itself is a mucolytic and antioxidant agent, but the placebo arm is inert and used to assess the true efficacy of the active drug through comparison.","oneSentence":"This is a placebo control arm with no active pharmacological mechanism.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:28:15.052Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT05142735","phase":"NA","title":"Effects of NAC on Symptoms of CHR Patients","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2023-01-13","conditions":"Prodromal Schizophrenia","enrollment":90},{"nctId":"NCT07273071","phase":"PHASE4","title":"Individualized Multiplex Pathophysiological Treatment of Severe Acute Infections: N-Acetylcysteine","status":"NOT_YET_RECRUITING","sponsor":"Theis S. Itenov","startDate":"2026-07","conditions":"Sepsis, Acute Infection, Severe Infection","enrollment":360},{"nctId":"NCT03493178","phase":"EARLY_PHASE1","title":"Glutathione in Mild Cognitive Impairment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2018-04-19","conditions":"Mild Cognitive Impairment","enrollment":60},{"nctId":"NCT04627922","phase":"PHASE4","title":"N-Acetylcysteine for Smoking Cessation in Tobacco and Cannabis Co-Use","status":"COMPLETED","sponsor":"Ellen Herbst","startDate":"2021-08-25","conditions":"Cannabis Use, Tobacco Use Disorder, Drug Use Disorder","enrollment":59},{"nctId":"NCT05122559","phase":"PHASE2","title":"Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emmanuelle Waubant, MD PhD","startDate":"2022-02-16","conditions":"Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive","enrollment":98},{"nctId":"NCT04520139","phase":"PHASE1, PHASE2","title":"Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT","status":"NOT_YET_RECRUITING","sponsor":"University of California, Irvine","startDate":"2026-03","conditions":"Ovarian Cancer, Cognitive Impairment","enrollment":102},{"nctId":"NCT03822637","phase":"PHASE4","title":"The Effect of NAC on Lung Function and CT Mucus Score","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2019-02-20","conditions":"Asthma","enrollment":4},{"nctId":"NCT05986318","phase":"PHASE2","title":"Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease","status":"RECRUITING","sponsor":"David Palma","startDate":"2025-01-07","conditions":"Lung Cancer, Interstitial Lung Disease","enrollment":98},{"nctId":"NCT04381897","phase":"PHASE2","title":"Use of N-Acetylcysteine in the Treatment of Repetitive and Self-Injurious Behaviors in Cornelia de Lange Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-08-01","conditions":"Cornelia de Lange Syndrome","enrollment":10},{"nctId":"NCT06311045","phase":"NA","title":"Obstructive Sleep Apnea (OSA) and Sex-Specific Responses to N-acetylcysteine (NAC)","status":"ACTIVE_NOT_RECRUITING","sponsor":"NYU Langone Health","startDate":"2024-05-07","conditions":"Obstructive Sleep Apnea","enrollment":14},{"nctId":"NCT05537220","phase":"PHASE3","title":"Oral N-acetylcysteine for Retinitis Pigmentosa","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2023-10-11","conditions":"Retinitis Pigmentosa","enrollment":485},{"nctId":"NCT04542161","phase":"PHASE2","title":"Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2020-09-01","conditions":"Chronic Fatigue Syndrome, Myalgic Encephalomyelitis","enrollment":95},{"nctId":"NCT04918719","phase":"PHASE2","title":"Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2023-11-02","conditions":"Acute Ischemic Stroke","enrollment":4},{"nctId":"NCT07414212","phase":"PHASE1, PHASE2","title":"Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosis (ALS)","status":"RECRUITING","sponsor":"Biogipuzkoa Health Research Institute","startDate":"2025-11-25","conditions":"Amyotrophic Lateral Sclerosis","enrollment":90},{"nctId":"NCT04013555","phase":"PHASE1, PHASE2","title":"The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2020-01-20","conditions":"Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder","enrollment":88},{"nctId":"NCT07391163","phase":"NA","title":"Protective Effect of N-acetylcysteine on Oxaliplatin-Induced Neuropathy in Colorectal Cancer","status":"COMPLETED","sponsor":"Tanta University","startDate":"2024-01-01","conditions":"Colorectal Cancer","enrollment":46},{"nctId":"NCT06850831","phase":"PHASE2","title":"Effect of Intracoronary N-Acetylcysteine in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention","status":"COMPLETED","sponsor":"dr. Ahmad Yasa, Sp.JP, Subsp.K.I.(K), M.Kes, FIHA, FasCC, FA","startDate":"2025-04-01","conditions":"STEMI - ST Elevation Myocardial Infarction (MI), Primary PCI - STEMI","enrollment":70},{"nctId":"NCT07374991","phase":"NA","title":"Clinical and Molecular Effects of N-Acetylcysteine Treatment in COVID-19-Related Acute Respiratory Distress Syndrome","status":"COMPLETED","sponsor":"University of Gaziantep","startDate":"2020-11-01","conditions":"COVID-19-Associated Acute Respiratory Distress Syndrome (ARDS)","enrollment":59},{"nctId":"NCT07360379","phase":"NA","title":"Comparing N-Acetylcysteine (NAC) Versus Alpha-Lipoic Acid (ALA) as Adjuncts for Postoperative Pain Management After Laparoscopic Appendectomy","status":"NOT_YET_RECRUITING","sponsor":"Ain Shams University","startDate":"2025-12-28","conditions":"Laparoscopic Appendectomy, Pain Management, Anti Oxidative Stress","enrollment":180},{"nctId":"NCT05664789","phase":"PHASE2, PHASE3","title":"Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Trial","status":"RECRUITING","sponsor":"Stanford University","startDate":"2023-04-26","conditions":"Autism Spectrum Disorder","enrollment":144},{"nctId":"NCT04278898","phase":"PHASE2","title":"Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Single-dose","status":"RECRUITING","sponsor":"Stanford University","startDate":"2021-02-12","conditions":"Autism Spectrum Disorder","enrollment":24},{"nctId":"NCT06956482","phase":"PHASE3","title":"PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic Hepatitis","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Lille","startDate":"2026-02","conditions":"Alcoholic Hepatitis","enrollment":477},{"nctId":"NCT07325383","phase":"PHASE3","title":"Safety and Efficacy of N-Acetylcysteine Mouthwash in Prevention of Mucositis in HSCT Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tehran University of Medical Sciences","startDate":"2024-08-18","conditions":"Oral Mucositis, Hematopoietic Stem Cell Transplantation (HSCT)","enrollment":106},{"nctId":"NCT07323446","phase":"EARLY_PHASE1","title":"The MIND Study: The MGH/MIT Investigation of NAC on Dysregulation","status":"NOT_YET_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2026-01-01","conditions":"Emotional Dysregulation","enrollment":120},{"nctId":"NCT07323719","phase":"NA","title":"Comparison Between Topical N-acetyl Cysteine (NAC) in Cold Cream Versus Cold Cream in Mild and Moderate Atopic Dermatitis: Clinical and Bacteriological Evaluation. A Randomized Control Trial.","status":"COMPLETED","sponsor":"Cairo University","startDate":"2024-05-30","conditions":"Atopic Dermatitis (AD)","enrollment":100},{"nctId":"NCT04784234","phase":"NA","title":"Vision Preservation and Restoration Following a 6 Month Trial of GlaucoCetin","status":"TERMINATED","sponsor":"Wills Eye","startDate":"2021-02-01","conditions":"Primary Open Angle Glaucoma","enrollment":12},{"nctId":"NCT07290530","phase":"PHASE3","title":"24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Nacuity Pharmaceuticals, Inc.","startDate":"2026-06","conditions":"Retinitis Pigmentosa (RP), Usher Syndrome","enrollment":80},{"nctId":"NCT07196852","phase":"NA","title":"Redox Status and Exercise Training-induced Adaptations","status":"RECRUITING","sponsor":"University of Thessaly","startDate":"2025-09-22","conditions":"Overweight (BMI > 25), Obesity","enrollment":60},{"nctId":"NCT06083480","phase":"PHASE4","title":"Reducing Perioperative Oxidative Stress to Prevent Postoperative Chronic Pain Following Total Knee Arthroplasty","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2024-12-06","conditions":"Osteoarthritis, Knee, Total Knee Arthroplasty, Chronic Postsurgical Pain","enrollment":148},{"nctId":"NCT05610072","phase":"EARLY_PHASE1","title":"Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine)","status":"RECRUITING","sponsor":"William Stoops","startDate":"2022-12-15","conditions":"Cocaine Use Disorder, Opioid Use Disorder, Stimulant Use Disorder","enrollment":24},{"nctId":"NCT05798481","phase":"EARLY_PHASE1","title":"Effect of Sublingually Generated S-nitroso-N-acetylcysteine on Systemic Blood Pressure.","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2024-03-27","conditions":"Hypertension, Cardiovascular Diseases","enrollment":14},{"nctId":"NCT05517668","phase":"PHASE2","title":"Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose","status":"TERMINATED","sponsor":"Richard Dart, MD, PhD","startDate":"2022-09-12","conditions":"Acetaminophen, Drug Overdose, Acetaminophen Overdose","enrollment":29},{"nctId":"NCT07245095","phase":"PHASE2","title":"Premedication With N-acetylcysteine and Simethicone to Improve Mucosal Visualization in Elective Upper Endoscopy","status":"RECRUITING","sponsor":"Hospital General de Mexicali","startDate":"2025-09-12","conditions":"Esophagogastroduodenoscopy, Simethicone, N-Acetylcysteine","enrollment":132},{"nctId":"NCT07049952","phase":"PHASE2, PHASE3","title":"BabySTrong II taVNS Feeding Trial","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2025-11-16","conditions":"Feeding Delays, Neonates and Term Infants","enrollment":88},{"nctId":"NCT05689645","phase":"PHASE2","title":"F573 for Injection for the Treatment of Liver Injury/Failure","status":"RECRUITING","sponsor":"Beijing Continent Pharmaceutical Co, Ltd.","startDate":"2023-03-24","conditions":"Acute Liver Failure, Acute-On-Chronic Liver Failure","enrollment":97},{"nctId":"NCT07227649","phase":"PHASE2","title":"NAC-REPAIR for Post-surgical Pain","status":"NOT_YET_RECRUITING","sponsor":"University of Arizona","startDate":"2026-01-15","conditions":"Carpal Tunnel Surgery, Trigger Finger Disorder, De Quervain Syndrome","enrollment":80},{"nctId":"NCT06727422","phase":"PHASE2","title":"Efficacy of Rifaximin With NAC in IBS-D","status":"NOT_YET_RECRUITING","sponsor":"Mark Pimentel, MD","startDate":"2025-12-15","conditions":"IBS (Irritable Bowel Syndrome), IBS-D (Diarrhea-predominant)","enrollment":225},{"nctId":"NCT01467466","phase":"PHASE3","title":"Prevention of Serious Adverse Events Following Angiography","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2013-10-07","conditions":"Acute Renal Failure, Kidney Disease, Coronary Artery Disease","enrollment":5177},{"nctId":"NCT06039566","phase":"PHASE3","title":"NAC vs Placebo on Opioid Use for Hysterectomy","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2023-11-30","conditions":"Hysterectomy","enrollment":240},{"nctId":"NCT04440280","phase":"PHASE2","title":"Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy","status":"RECRUITING","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2020-09-16","conditions":"Fuchs Endothelial Corneal Dystrophy","enrollment":45},{"nctId":"NCT04155632","phase":"PHASE2","title":"Neurocircuit Strategy to Decrease Cocaine Cue Reactivity","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2020-12-18","conditions":"Cocaine-Related Disorders","enrollment":32},{"nctId":"NCT03843541","phase":"PHASE3","title":"A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions","status":"COMPLETED","sponsor":"Zambon SpA","startDate":"2019-06-25","conditions":"Respiratory Tract Diseases, Abnormal Mucus Secretions","enrollment":333},{"nctId":"NCT06956157","phase":"PHASE4","title":"NAC for Treatment-Resistant OCD and Other Related Disorders","status":"ACTIVE_NOT_RECRUITING","sponsor":"Guangdong Provincial People's Hospital","startDate":"2022-06-22","conditions":"Obsessive Compulsive Disorder (OCD)","enrollment":90},{"nctId":"NCT06486805","phase":"PHASE4","title":"N-Acetyl Cysteine Effect on Liver Function After Mitral Valve Replacement","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2024-06-30","conditions":"Oxidative Stress, Liver Dysfunction","enrollment":54},{"nctId":"NCT04154982","phase":"PHASE2","title":"N-Acetylcysteine Protection Against Radiation Induced Cellular Damage","status":"COMPLETED","sponsor":"Centro Cardiologico Monzino","startDate":"2020-09-02","conditions":"Cardiac Arrhythmia","enrollment":181},{"nctId":"NCT04959864","phase":"NA","title":"Efficacy Study of a Food Supplement With Myo-inositol, N-Acetyl-Cystein, Zinc and Vitamins on Sperm DNA Fragmentation","status":"RECRUITING","sponsor":"GYNOV","startDate":"2021-07-07","conditions":"Male Infertility","enrollment":72},{"nctId":"NCT04923659","phase":"EARLY_PHASE1","title":"Pharmacological Mechanisms of Low-intensity Focused Ultrasound for Motor Cortex Neuroplasticity","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2021-05-25","conditions":"Low Intensity Focussed Ultrasound","enrollment":20},{"nctId":"NCT04481035","phase":"PHASE2","title":"Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibromatosis Type 1","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2019-01-15","conditions":"Neurofibromatosis 1","enrollment":5},{"nctId":"NCT07093944","phase":"PHASE2","title":"Randomized, Placebo-Controlled Trial of N-acetylcysteine In Parkinson's Disease Patients: A Pilot Study","status":"COMPLETED","sponsor":"Kurdistan University of Medical Sciences","startDate":"2018-04-09","conditions":"Parkinson's Disease (PD)","enrollment":42},{"nctId":"NCT05944458","phase":"PHASE4","title":"Efficacy of Intravenous N-Acetylcysteine in Preventing Linezolid-Induced Thrombocytopenia in Critically Ill Patients","status":"COMPLETED","sponsor":"Helwan University","startDate":"2023-08-01","conditions":"Linezolid, Antioxidant, Thrombocytopenia","enrollment":250},{"nctId":"NCT02804594","phase":"PHASE2","title":"A Study of Oxidative Pathways in MS Fatigue","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2016-10-01","conditions":"Progressive Multiple Sclerosis, Fatigue","enrollment":15},{"nctId":"NCT04987775","phase":"EARLY_PHASE1","title":"GWICTIC: NAC Mechanistic Study in Gulf War Veterans","status":"RECRUITING","sponsor":"Nova Southeastern University","startDate":"2023-11-30","conditions":"Gulf War Syndrome","enrollment":170},{"nctId":"NCT05485558","phase":"PHASE2","title":"the Safety and Efficacy of N-acetyl Cysteine in Children With Drug-Resistant Epilepsy","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-09-15","conditions":"Drug Resistant Epilepsy","enrollment":90},{"nctId":"NCT04740580","phase":"EARLY_PHASE1","title":"Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2022-02-15","conditions":"Alzheimer Disease","enrollment":52},{"nctId":"NCT06367413","phase":"NA","title":"Effects of Protein and NAC Co-ingestion on Skeletal Muscle Recovery","status":"RECRUITING","sponsor":"University of Thessaly","startDate":"2024-04-08","conditions":"Aseptic Muscle Injury","enrollment":30},{"nctId":"NCT02719392","phase":"PHASE4","title":"A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Bipolar Depression","status":"SUSPENDED","sponsor":"Massachusetts General Hospital","startDate":"2017-08-09","conditions":"Bipolar Disorder, Bipolar Depression","enrollment":40},{"nctId":"NCT02750319","phase":"PHASE3","title":"Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2016-04","conditions":"Thoracic Surgery, Atrial Fibrillation in High Risk Patients","enrollment":184},{"nctId":"NCT05309070","phase":"NA","title":"The Efficacy of N-acetyl-cysteine in the Treatment of Burning Mouth Syndrome","status":"COMPLETED","sponsor":"University of Zagreb","startDate":"2022-05-01","conditions":"Burning Mouth Syndrome","enrollment":80},{"nctId":"NCT06581783","phase":"NA","title":"Impact of Timing of Premedication on Mucosal Visibility During Endoscopy-A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Asian Institute of Gastroenterology, India","startDate":"2024-12-01","conditions":"Endoscopy, Digestive System","enrollment":1200},{"nctId":"NCT00585559","phase":"PHASE3","title":"Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm","status":"TERMINATED","sponsor":"Vanderbilt University Medical Center","startDate":"2007-04","conditions":"Aneurysmal Subarachnoid Hemorrhage, Cerebral Vasospasm","enrollment":44},{"nctId":"NCT06377631","phase":"NA","title":"Effect of Multi-ingredient on Visceral Adiposity & Non-alcoholic Fatty Liver Disease in Postmenopausal Women With Abdominal Obesity","status":"COMPLETED","sponsor":"Fundació Eurecat","startDate":"2024-06-07","conditions":"Visceral Obesity, Non-alcoholic Fatty Liver, Postmenopausal","enrollment":50},{"nctId":"NCT03306979","phase":"PHASE2","title":"Memory and Antioxidants in Vascular Impairment Trial","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2018-04-30","conditions":"Vascular Cognitive Impairment no Dementia","enrollment":60},{"nctId":"NCT06811675","phase":"PHASE4","title":"The Efficacy of Dexamethasone in Combination With N-acetylcysteine in Preventing Neurocognitive Sequelae Due to Carbon Monoxide Poisoning","status":"RECRUITING","sponsor":"China Medical University Hospital","startDate":"2025-03-23","conditions":"Carbon Monoxide Poisoning, Delayed Neurocognitive Sequelae","enrollment":128},{"nctId":"NCT06890507","phase":"PHASE2","title":"The Anti-Anginal Effects of N-Acetylcysteine (NAC) in Patients with Angina and Non-Obstructive Coronary Arteries (ANOCA)","status":"NOT_YET_RECRUITING","sponsor":"University of Adelaide","startDate":"2025-06-01","conditions":"Angina Attacks, Non Obstructive Coronary Artery Disease","enrollment":25},{"nctId":"NCT05509153","phase":"PHASE2","title":"A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers","status":"RECRUITING","sponsor":"Western Sydney Local Health District","startDate":"2024-06-01","conditions":"Huntington Disease","enrollment":160},{"nctId":"NCT04573153","phase":"PHASE2, PHASE3","title":"Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients","status":"TERMINATED","sponsor":"ScandiBio Therapeutics AB","startDate":"2020-09-21","conditions":"COVID-19","enrollment":100},{"nctId":"NCT04330326","phase":"PHASE2","title":"Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease","status":"COMPLETED","sponsor":"ScandiBio Therapeutics AB","startDate":"2019-07-20","conditions":"Non-alcoholic Fatty Liver Disease (NAFLD)","enrollment":32},{"nctId":"NCT03423667","phase":"PHASE2","title":"Efficacy of N-acetylcysteine on the Craving Symptoms of Abstinent Hospitalized Patients With Cocaine Addiction","status":"TERMINATED","sponsor":"Salvatore Campanella","startDate":"2019-03-01","conditions":"Cocaine Addiction","enrollment":33},{"nctId":"NCT02966873","phase":"PHASE2","title":"Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2016-10-01","conditions":"Post Traumatic Stress Disorder (PTSD), Addiction, Alcohol Abuse","enrollment":182},{"nctId":"NCT04793646","phase":"NA","title":"N-acetylcysteine for Primary Sjögren's Syndrome","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2021-04-30","conditions":"Sjögren Syndrome, Sicca Syndrome","enrollment":60},{"nctId":"NCT03707951","phase":"PHASE2","title":"N-Acetylcysteine for Adolescent Alcohol Use Disorder","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2019-02-27","conditions":"Alcohol Use Disorder","enrollment":126},{"nctId":"NCT06693362","phase":"PHASE1","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses","status":"RECRUITING","sponsor":"Ruijin Hospital","startDate":"2025-01-20","conditions":"Severe Viral Pneumonia(Not Include COVID-19)","enrollment":60},{"nctId":"NCT00775476","phase":"PHASE2","title":"Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine","status":"RECRUITING","sponsor":"State University of New York - Upstate Medical University","startDate":"2022-05-05","conditions":"Systemic Lupus Erythematosus","enrollment":290},{"nctId":"NCT03711838","phase":"NA","title":"Redox Regulation of Satellite Cells and Skeletal Muscle Healing","status":"COMPLETED","sponsor":"University of Thessaly","startDate":"2019-07-22","conditions":"Satellite Cells, Redox Status, Exercise-induced Muscle Trauma","enrollment":45},{"nctId":"NCT00780962","phase":"PHASE2","title":"N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department Patients","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2007-10-16","conditions":"Radiocontrast Nephropathy","enrollment":399},{"nctId":"NCT05041179","phase":"NA","title":"Bioavailability of PRUVIN® and Its Effects in Healthy Subjects (INDIGO)","status":"COMPLETED","sponsor":"Société des Produits Nestlé (SPN)","startDate":"2019-04-01","conditions":"Oxidative Stress","enrollment":128},{"nctId":"NCT04481048","phase":"PHASE2","title":"Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2020-12-15","conditions":"Neurofibromatosis 1","enrollment":58},{"nctId":"NCT05903014","phase":"PHASE4","title":"Effectiveness of N-Acetylcysteine (NAC) in Motivational Enhancement Therapy for Nicotine Addiction","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2023-01-01","conditions":"Nicotine Dependence, Nicotine Addiction","enrollment":90},{"nctId":"NCT00558142","phase":"PHASE4","title":"Mechanisms for the Effect of Acetylcysteine on Renal Function After Exposure to Radiographic Contrast Material","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2008-02","conditions":"Radiocontrast-induced Nephropathy","enrollment":107},{"nctId":"NCT04460521","phase":"PHASE4","title":"The ACTS Trial: N-acetylcysteine (NAC) and Night-splinting as a Non-operative Treatment for Carpal Tunnel Syndrome","status":"RECRUITING","sponsor":"Emily Krauss","startDate":"2022-04-01","conditions":"Carpal Tunnel Syndrome, Hand Injuries and Disorders, Nerve Compression","enrollment":240},{"nctId":"NCT03253328","phase":"EARLY_PHASE1","title":"N-Acetyl-Cysteine (NAC) for Healing of Amputation Stumps in the Setting of Diabetes","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2017-03-01","conditions":"Diabetes Mellitus, Critical Limb Ischemia, Lower Limb Amputation Knee","enrollment":33},{"nctId":"NCT05340504","phase":"PHASE2","title":"Evaluating the Hypothesized Mechanism of Action of N-acetylcysteine for Bipolar Disorder","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2022-05-13","conditions":"Bipolar Disorder, Bipolar I Disorder, Bipolar II Disorder","enrollment":12},{"nctId":"NCT04703036","phase":"EARLY_PHASE1","title":"Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19","status":"TERMINATED","sponsor":"Baylor College of Medicine","startDate":"2021-01-11","conditions":"Covid19","enrollment":4},{"nctId":"NCT06384833","phase":"PHASE4","title":"Combination of Vitamin C and N-Acetylcysteine to Improve Functional Outcome After Rotator Cuff Repair","status":"NOT_YET_RECRUITING","sponsor":"Mahidol University","startDate":"2024-05-01","conditions":"Rotator Cuff Tears","enrollment":110},{"nctId":"NCT05287724","phase":"EARLY_PHASE1","title":"Defining N-Acetyl Cysteine as a Treatment for Inhibiting Prurogenic Stimuli","status":"COMPLETED","sponsor":"Wright State University","startDate":"2022-06-19","conditions":"Pruritus, Skin Disorder","enrollment":20},{"nctId":"NCT05807204","phase":"NA","title":"Effect of a Multi-ingredient on Visceral Adiposity and Non-alcoholic Fatty Liver Disease in Individuals With Abdominal Obesity","status":"COMPLETED","sponsor":"Fundació Eurecat","startDate":"2023-05-01","conditions":"Visceral Obesity, Non-Alcoholic Fatty Liver Disease","enrollment":20},{"nctId":"NCT04594733","phase":"PHASE1, PHASE2","title":"The Effect of Minocycline and N-acetylcysteine for the Treatment of Fibromyalgia","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2021-12-06","conditions":"Fibromyalgia","enrollment":14},{"nctId":"NCT06202911","phase":"PHASE4","title":"Effect of Oral N-Acetyl Cysteine in Prevention of Necrotizing Enterocolitis in Preterm Neonates With Feeding Intolerance","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2023-01-01","conditions":"Preterm Neonates and Feeding Intolerance, Necrotizing Enterocolitis, Oral N-acetyl Cysteine","enrollment":100},{"nctId":"NCT05215743","phase":"PHASE1","title":"Combined Antioxidant Therapy Against Myocardial Reperfusion Injury. Phase I Study.","status":"COMPLETED","sponsor":"University of Chile","startDate":"2022-08-09","conditions":"Acute Myocardial Infarction, Ischemia-reperfusion Injury, Reperfusion Injury, Myocardial","enrollment":18},{"nctId":"NCT05557448","phase":"PHASE2","title":"To Evaluate the Efficacy and Safety of TYNADOTE® in the Treatment of Acetaminophen Overdose","status":"RECRUITING","sponsor":"Sinew Pharma Inc.","startDate":"2023-05-01","conditions":"Hepatitis","enrollment":24},{"nctId":"NCT03220776","phase":"PHASE2","title":"Imaging GABAergic/Glutamatergic Drugs in Bipolar Alcoholics Alcoholics","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2017-08-07","conditions":"Alcohol Use Disorder, Bipolar Disorder","enrollment":54},{"nctId":"NCT03900988","phase":"PHASE3","title":"Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia","status":"UNKNOWN","sponsor":"Chinese University of Hong Kong","startDate":"2023-05-08","conditions":"Influenza","enrollment":160},{"nctId":"NCT05706402","phase":"PHASE3","title":"N-acetylcysteine (NAC) for the Treatment of Acute Exacerbation of COPD","status":"UNKNOWN","sponsor":"Queen Mary Hospital, Hong Kong","startDate":"2023-09-18","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":80},{"nctId":"NCT06039280","phase":"NA","title":"Comparison of Dexamethasone and N Acetylcysteine (NAC) Versus N Acetylcysteine (NAC) Alone in the Prevention of Post Embolization Syndrome in Patients With Hepatocellular Carcinoma Following Transarterial Chemoembolization.","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2023-09-15","conditions":"Hepatocellular Carcinoma","enrollment":150},{"nctId":"NCT04005053","phase":"PHASE2","title":"Signatures of N-Ac for Non-Suicidal Self-Injury in Adolescents","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2019-08-01","conditions":"Self-Harm, Depression, Suicide","enrollment":44},{"nctId":"NCT05074121","phase":"PHASE2","title":"NAC for Attenuation of COVID-19 Symptomatology","status":"UNKNOWN","sponsor":"Cambridge Health Alliance","startDate":"2024-03-31","conditions":"Covid19, COVID-19 Pneumonia, COVID-19 Respiratory Infection","enrollment":200},{"nctId":"NCT05951712","phase":"NA","title":"Pre-medication With N-acetylcysteine and Simethicone to Improve Mucosal Visibility During Gastroduodenoscopy","status":"COMPLETED","sponsor":"Asian Institute of Gastroenterology, India","startDate":"2022-06-16","conditions":"Mucosal Erosion","enrollment":800},{"nctId":"NCT04964843","phase":"PHASE2","title":"A Study of NAC for AUD","status":"WITHDRAWN","sponsor":"Uniformed Services University of the Health Sciences","startDate":"2023-04","conditions":"Alcohol Use Disorder","enrollment":""},{"nctId":"NCT02124941","phase":"PHASE1","title":"Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 1H-MRS","status":"COMPLETED","sponsor":"Yale University","startDate":"2014-02","conditions":"Cocaine Dependence, Healthy","enrollment":6},{"nctId":"NCT03238300","phase":"PHASE2","title":"Neuroscience-Informed Treatment Development for Adolescent Alcohol Use","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2017-10-16","conditions":"Alcohol Drinking, Control","enrollment":57}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo of N-acetylcysteine","genericName":"Placebo of N-acetylcysteine","companyName":"University Hospital, Lille","companyId":"university-hospital-lille","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}